Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2)

INTRODUCTION: Administered basal insulin markedly influences the fasting plasma glucose (FPG) level of individuals with type 1 diabetes. Insulin degludec (IDeg) and insulin glargine U300 (IGlar U300) are now available as ultra-long-acting insulin formulations, but whether or how their glucose-stabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Hiroshi, Sakaguchi, Kazuhiko, Okada, Yuko, Otowa-Suematsu, Natsu, Yamada, Tomoko, So, Anna, Komada, Hisako, Hirota, Yushi, Kishi, Minoru, Takeda, Akihiko, Tominaga, Yoichi, Nakamura, Tomoaki, Kuroki, Yasuo, Matsuda, Tomokazu, Iida, Keiji, Kajikawa, Michiko, Ohara, Takeshi, Yokota, Kazuki, Hara, Kenta, Tateya, Sanshiro, Tamori, Yoshikazu, Ogawa, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250619/
https://www.ncbi.nlm.nih.gov/pubmed/30341665
http://dx.doi.org/10.1007/s13300-018-0523-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250619/
https://www.ncbi.nlm.nih.gov/pubmed/30341665
http://dx.doi.org/10.1007/s13300-018-0523-0

Ejemplares similares